Document is current
Any future updates will be listed below
-
Authors
Mthethwa, Mashudu
Mbeye, Nyanyiwe Masingi
Effa, Emmanuel
Arikpo, Dachi
Blose, Ntombifuthi
Brand, Amanda
Chibuzor, Moriam
Chipojola, Roselyn
Durao, Solange
Esu, Ekpereonne
Kallon, Idriss Ibrahim
Kunje, Gertrude
Lakudzala, Suzgika
Naude, Celeste
Leong, Trudy D.
Lewin, Simon
Mabetha, Denny
McCaul, Michael
Meremikwu, Martin
Vandvik, Per Olav
Kredo, Tamara
-
Funding
Funding for this research was provided by:
European and Developing Countries Clinical Trials Partnership (RIA2020S-3303-GELA)
- License Information
-
More Information
Article History
Received: 26 March 2023
Accepted: 5 February 2024
First Online: 19 February 2024
Declarations
:
: Not applicable as all data reported are from publicly available sources.
: Not applicable.
: Tamara Kredo is a member of the GRADE working group; co-Director of South African GRADE Network; a member of National Essential Medicines List Committee in South Africa which reviews and ratifies national standard treatment guidelines; member of the Cochrane Board. All views expressed are her own. Other authors do not have any competing interest.
